C07D 487/16
Peri-condensed systems
C07D487/16 (Peri-condensed systems) appears on 212 US grants and 300 published applications in this corpus.
Search patents in C07D- Granted patents
- 212
- Published applications
- 300
- Assignees
- 158
- Inventors
- 857
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 3 | 5 |
| 2003 | 5 | 1 |
| 2004 | 1 | 6 |
| 2005 | 1 | 1 |
| 2006 | 0 | 3 |
| 2007 | 0 | 4 |
| 2008 | 1 | 4 |
| 2009 | 4 | 11 |
| 2010 | 2 | 7 |
| 2011 | 0 | 5 |
| 2012 | 3 | 8 |
| 2013 | 4 | 10 |
| 2014 | 9 | 24 |
| 2015 | 18 | 14 |
| 2016 | 19 | 18 |
| 2017 | 15 | 23 |
| 2018 | 20 | 18 |
| 2019 | 16 | 22 |
| 2020 | 12 | 19 |
| 2021 | 9 | 15 |
| 2022 | 11 | 24 |
| 2023 | 11 | 21 |
| 2024 | 11 | 12 |
| 2025 | 11 | 13 |
| 2026 | 12 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Materials for organic electroluminescent devices15 Sep 2026US 12,735,436 B2Universal Display Corporation
- Tricyclic derivatives and related uses1 Sep 2026US 12,723,045 B2MOMA Therapeutics, Inc.
- Composition material for organic electroluminescent device, plurality of host materials, and organic electroluminescent device comprising the same25 Aug 2026US 12,721,039 B2DuPont Specialty Materials Korea Ltd.
- Indolo[3.2.1-jk]carbazole-6-carbonitrile derivatives as blue fluorescent emitters for use in OLEDS21 Jul 2026US 12,690,385 B2
- Plurality of host materials and organic electroluminescent device comprising the same23 Jun 2026US 12,666,865 B2DuPont Specialty Materials Korea Ltd.
- Heterocyclic compounds as parp1 inhibitors1 Oct 2026US 2026/0297102 A1Synnovation Therapeutics, Inc.
- Cyclic compounds used as multi-target kinase inhibitors and preparation method therefor24 Sep 2026US 2026/0285873 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Plurality of host materials and organic electroluminescent device comprising the same10 Sep 2026US 2026/0271617 A1
- Nitrogen-containing hetreocycles for organic electroluminescent devices27 Aug 2026US 2026/0255779 A1Merck Patent GmbH
- Substituted benzene compound6 Aug 2026US 2026/0226065 A1Daiichi Sankyo Company, Limited
Most cited
By later US patents
- Tetracyclic azepinoindole compounds100US 6,407,092 B1Pharmacia & Upjohn Company · 2002
- Alternative nucleic acid molecules and uses thereof81US 10,286,086 B2ModernaTX, Inc. · 2019
- Annelated indolo [3,2,-C]lactams42US 5,223,625 ADuphar International Research B.V. · 1993
- Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections30US 8,093,380 B2Pharmasset, Inc. · 2012
- CRF receptor antagonists and methods relating thereto28US 6,583,143 B2Neurocrine Biosciences, Inc. · 2003